首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Lancet regional health-europe

缩写:

ISSN:2666-7762

e-ISSN:2666-7762

IF/分区:15.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1673条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Katharina A Mayer,Matthias Diebold,Eva V Schrezenmeier et al. Katharina A Mayer et al.
Background: Antibody-mediated rejection (AMR) is a major cause of kidney transplant failure. The CD38 antibody felzartamab has been shown to reduce AMR activity, but recurrence after stopping treatment suggested a need fo...
Cindy Poirier,Nicolas Terzi,Nicolas Roesch et al. Cindy Poirier et al.
Background: Community-acquired bacterial meningitis remains associated with high mortality and neurological disability in critically ill adults. Contemporary data on outcomes in mechanically ventilated patients and on the...
Annejet A Schenck,Raymond van de Berg,Thomas T A Peters et al. Annejet A Schenck et al.
Background: Treatment for Ménière's disease remains a subject of debate. A surgical technique in which the endolymphatic duct is blocked was proposed as a new treatment modality for patients with intractable Ménière's...
Susanna Klevebro,Carina Uhl,Jon Roald Konradsen et al. Susanna Klevebro et al.
Background: Oral immunotherapy (OIT) is an emerging treatment for peanut allergy. A variety of protocols have been investigated, and accumulating evidence suggests that younger children may benefit from greater immune pla...
Søren Holm,Manuel Tena-Sempere,Dimitrios Koutsouris et al. Søren Holm et al.
Obesity rates continue to rise across Europe, driven by obesogenic environments shaped by food systems, urban design, socioeconomic inequalities, and commercial forces. The introduction of incretin-based pharmacotherapies like GLP-1 recepto...
Massimo Filippi,Giordano Cecchetti,Alma Ghirelli et al. Massimo Filippi et al.
The introduction of anti-amyloid monoclonal antibodies has shifted Alzheimer's disease care from diagnostic clarification alone to the problem of treatment governance. While lecanemab and donanemab have demonstrated amyloid reduction at the...